Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: Fred Levine who wrote (925)	8/6/1999 7:54:00 AM
From: QuietWon	Read Replies (1) \| Respond to of 2515

Sure I'm grateful, but what kind of bullcrap is this that goes on in the market: 1) we get an accumulate a week and a bit ago from Prudential. Then we get a stong buy yesterday. Given a $3-4 difference, it's a 2 level upgrade? What changed in a week or so? Prudential likely had got clients into the stock, and probably before they issued the Accumulate rating ...and that may have been at prices higher than $25 (the level at which it sort of hung around at before falling) At least Pru not as bad as Merrill who last year downgraded NOK at about 62-65. Yeah, and NOK dropped to 60, then within a few weeks to a month was up at $90 ! and NOK has gone on another $60 or $70 on top of that mark. 2) who the heck is this Oscar Guss firm? why weren't they around 7 or 8 months back?? Again, maybe there were some clients in at higher prices. Sort of reminds me of that shorting guy Asensio - they both issue PR's from their firm, over the i-net. Well, why don't we all start posting our own news stories over the internet?? Total bullcrap that goes on, imo, just like those 780 call options in one block, back in March or so...and then a week or so later, Individual Investor Online has an article from industry expert Jim McCamant. Gimme a break. If anyone out there with great investigational skills could identify, or come close to identifying, the source of that trade, and see if there is any connection to the news article, that would sure be interesting. A Quiet editorial to start the day.

To: Fred Levine who wrote (925)	8/10/1999 5:03:00 PM
From: caly	Read Replies (1) \| Respond to of 2515

Post from Yahoo... Spoke to IMCL by: pharmainvestor11 2480 of 2480 SUMMARY 1. Neck & head cancer · C225 + radiation (416 patients) PH3 completion in 3Q 00 · C225 + drug (forgot it name) PH3 completion in 4Q 00 · For both IMCL will get an outside house to review the results · NDA filing (their timetable) 2Q 01 2. Other cancers In 2H 99 will start PH2 for pancreatic, colon, and non-small cell lungs cancers 3. No conference presentations are scheduled in 99. 4. There is no "poison pill" against takeover. Therefore, in the next 5-8 months will be no news and a lot of speculations! Pharma